NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/15/2026
Back to search
Official data from USPTO
AACE ENDOCRINOLOGY AND DIABETES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AACE ENDOCRINOLOGY AND DIABETES
ST13
US500000099975043Class
9
Filing
99975043
Registration
8263662
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
06/16/2026
Trademark type
Word
Nice classes
9
Filing date
05/01/2025
Registration date
05/19/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/19/2026
Last transaction
06/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/29/2025
First use in commerce
05/29/2025
Drawing code
4
Owner type
54
Owner location
Jacksonville, FL, US
Examiner
FITZSIMONS, MICHAEL R
Law office
L30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
American Association of Clinical Endocrinologists, Inc.
Representatives
Richard S. Vermut DRIVER, MCAFEE, HAWTHORNE & DIEBENOW, PLLC
Technical classification
Nice Classes
Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable electronic publications in the nature of journals and articles in the field of endocrinology and diabetes; Electronic downloadable publicationsjournals and articles for use by medical professionals in the field of science and medicine; Downloadable educational publicationsprintable journals and articles in the field of endocrinology and diabetes
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/19/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/31/2026
PUBO
PUBLISHED FOR OPPOSITION
03/31/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/25/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/10/2026
IUAA
USE AMENDMENT ACCEPTED
03/10/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
03/10/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/10/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
03/10/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/10/2026
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
03/03/2026
DPCC
DIVISIONAL PROCESSING COMPLETE
03/03/2026
DOCK
ASSIGNED TO EXAMINER
09/19/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
07/21/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/12/2025
ALIE
ASSIGNED TO LIE
06/10/2025
IUAF
USE AMENDMENT FILED
06/03/2025
DRRR
DIVISIONAL REQUEST RECEIVED
06/03/2025
EAAU
TEAS AMENDMENT OF USE RECEIVED
06/03/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
06/03/2025
MAFR
APPLICATION FILING RECEIPT MAILED
05/01/2025
NWAP
NEW APPLICATION ENTERED
05/01/2025
Continuous trademark protection
Get notified about every new filing that threatens AACE ENDOCRINOLOGY AND DIABETES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.